Axa’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,500
Closed -$375K 1192
2022
Q3
$375K Buy
+11,500
New +$425K ﹤0.01% 1007
2017
Q3
Sell
-40,000
Closed -$1.12M 1349
2017
Q2
$1.12M Hold
40,000
0.01% 910
2017
Q1
$1.12M Sell
40,000
-68,800
-63% -$1.76M 0.01% 908
2016
Q4
$2.37M Sell
108,800
-12,600
-10% -$261K 0.01% 736
2016
Q3
$2.46M Sell
121,400
-4,200
-3% -$82.5K 0.01% 709
2016
Q2
$2.26M Buy
125,600
+21,100
+20% +$392K 0.01% 722
2016
Q1
$1.93M Sell
104,500
-9,000
-8% -$143K 0.01% 756
2015
Q4
$1.67M Buy
+113,500
New +$1.71M 0.01% 815

Other funds holding MXL

Axa's MXL Position: Q4 2022 in Review

Axa sold out of MaxLinear (MXL) in Q4 2022, closing a stake of 11,500 shares — an estimated $375K sold.

Axa first reported a position in MXL in Q4 2015 and held it in 8 quarters. The position peaked at $2.46M in Q3 2016. 280 funds tracked by Wall St. Rank hold MXL as of Q4 2022.

  • Axa reported no remaining MaxLinear position as of Q4 2022 after selling out during the quarter.
  • Axa sold 11,500 MaxLinear shares in Q4 2022, an estimated $375K.
  • Axa first reported a position in MaxLinear in Q4 2015 and held it in 8 quarters.
  • Axa's MaxLinear position peaked at $2.46M in Q3 2016.
  • 280 funds tracked by Wall St. Rank held MaxLinear as of Q4 2022.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.